RecruitingNCT05521451

Clinical Cohort Study - TRUST

Longterm Outcome and Predictors for Recurrence After Medical and Interventional Treatment of Arrhythmias At the University Heart Center Hamburg

Sponsor

Universitätsklinikum Hamburg-Eppendorf

Enrollment

5,000 participants

Start Date

Mar 17, 2021

Study Type

OBSERVATIONAL

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Supraventricular Tachycardia Atrial Flutter Ventricular Tachycardia Atrial Tachycardia Arrhythmogenic Right Ventricular Dysplasia Long QT Syndrome Brugada Syndrome Catecholaminergic Polymorphic Ventricular Tachycardia

Summary

The "Long-term Outcome and Predictors for Recurrence after Medical and Interventional Treatment of Arrhythmias at the University Heart Center Hamburg" (TRUST) study is an investor-initiated, single-center, prospective clinical cohort study including patients treated with cardiac arrhythmias or at high risk for cardiac arrhythmias. The design enables prospective, low-threshold, near complete inclusion of patients with arrhythmias treated at the UHZ. Collection of routine follow-up data, detailed procedural information and systematic biobanking will enable precise and robust phenotyping.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is building a clinical registry of patients in Germany with heart rhythm disorders (arrhythmias), including those who are at high risk for developing arrhythmias, to better understand long-term outcomes and treatment patterns. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with a cardiac arrhythmia (including congenital arrhythmias) or are at high risk for one - You are willing and able to give written informed consent **You may NOT be eligible if...** - You do not have a sufficient understanding of German to understand study documents and interviews - You have a physical or psychological condition that prevents you from taking part Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.